The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| U.S.-Russia Bilateral Collaborative Research Partnerships on Cancer (R21) |
93.393, 93.394, 93.395, 93.396 |
RFA-CA-16-015 |
| Elucidation of Mechanisms of Radiation-Induced Endovascular Injury and Development of Treatments / Mitigators for Radiation-Induced Endothelial Cell and Vascular Dysfunction (U01) |
93.855, 93.856 |
RFA-AI-16-053 |
| Peer Reviewed Orthopaedic Clinical Trial Award |
12.420 |
W81XWH-16-PRORP-CTA |
| Chemical Discovery (CHEM) Award (R21/R33) |
93.279 |
PAR-16-384 |
| Chemistry Science Track Award for Rapid Transition (C/START) (R03) |
93.279 |
PAR-16-383 |
| Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Biostatistics Research Center (Collaborative U01) |
93.847 |
RFA-DK-16-509 |
| Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Clinical Research Center (Collaborative U01) |
93.847 |
RFA-DK-16-508 |
| Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02) |
93.846 |
PAR-16-381 |
| Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (R61/R33) |
93.846 |
RFA-AR-17-008 |
| Environmental Health Cohorts Maintenance and Infrastructure (R24) |
93.113 |
RFA-ES-16-004 |
| Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02) |
93.846 |
PAR-16-382 |
| Research Innovations for Scientific Knowledge (RISK) for Musculoskeletal Diseases (R61/R33) |
93.846 |
RFA-AR-17-009 |
| Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01) |
93.393 |
PAR-16-380 |
| Center of Excellence for Research on Complementary and Integrative Health (P01) |
93.213 |
PAR-16-379 |
| Data and Modeling Coordination Center for the NHLBI's Precision Interventions for Severe and/or Exacerbation-Prone Asthma (PrecISE) Network (U24) |
93.838 |
RFA-HL-17-010 |
| Clinical Centers for the NHLBI's Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE) Network (UG1) |
93.838 |
RFA-HL-17-009 |
| Limited Competition: Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study (U01) |
93.847 |
RFA-DK-16-511 |
| Mechanisms of Immune Activation and Inflammation: HIV Infection, ART, and Drugs of Abuse (R01) |
93.279 |
RFA-DA-17-013 |
| NINDS CREATE Devices: Translational and Clinical Studies to Inform Final Device Design (U44) |
93.853 |
PAR-14-300 |
| Strengthening the National Institutes of Health in the Republic of Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR) |
93.067 |
CDC-RFA-GH11-115804CONT14 |
| Direct Phase II SBIR Grants to Support Biomedical Technology Development |
93.121, 93.172, 93.173, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.350, 93.351, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.846, 93.853, 93.855, 93.856, 93.859, 93.865, 93.866, 93.867 |
PAR-14-088 |
| Bridges to the Doctorate Program (R25) |
93.859 |
PAR-11-279 |
| Building Interdisciplinary Research Careers in Womens Health (K12) |
93.113, 93.242, 93.273, 93.279, 93.398, 93.846, 93.856, 93.865, 93.866 |
RFA-OD-11-002 |
| Clinical Trials in Organ Transplantation (CTOT) (U01) |
93.855, 93.856 |
RFA-AI-13-006 |
| Support of NIGMS Program Project Grants (P01) |
93.172, 93.859 |
PAR-13-280 |
| Limited Competition: NIMHD Research Centers in Minority Institutions Infrastructure for Clinical and Translational Research (RCTR) [U54] |
93.307 |
PAR-13-279 |
| Host-Targeted Interventions as Therapeutics for Infectious Diseases (R21/R33) |
93.855, 93.856 |
RFA-AI-11-032 |
| Alzheimer's Clinical Trials Consortium (ACTC) (U24) |
93.866 |
RFA-AG-17-005 |
| Limited Competition: Clinical Research Investigator Supplement (CRIS) for the Maternal Fetal Medicine Units (MFMU) Network and the Neonatal Research Network (NRN) (Admin Supp) |
93.865 |
PA-16-377 |
| PHS 2016-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) |
93.067, 93.073, 93.083, 93.084, 93.103, 93.113, 93.118, 93.121, 93.135, 93.136, 93.172, 93.173, 93.213, 93.233, 93.242, 93.262, 93.273, 93.279, 93.286, 93.307, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.595, 93.647, 93.837, 93 |
PA-16-302 |
| The Role of Mobile Genetic Elements in Cancer (R21) |
93.396, 93.866 |
PAR-16-226 |
| Effects of Drugs of Abuse on Latent HIV Reservoirs in the CNS (R01) |
93.279 |
RFA-DA-16-014 |
| Improving Diabetes Management in Children with Type 1 Diabetes (DP3) |
93.847 |
RFA-DK-16-003 |
| Understanding Barriers and Facilitators to Type 1 Diabetes Management in Adults (DP3) |
93.847 |
RFA-DK-16-002 |
| Elucidating HIV and HIV-treatment Associated Metabolic/Endocrine Dysfunction (R01) |
93.847 |
RFA-DK-16-014 |
| Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R01) |
93.213, 93.361 |
PA-16-030 |
| Innovative Research in HIV in Kidney, Urology, and Hematology (R01) |
93.847 |
RFA-DK-16-015 |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate the Discovery of Neurotherapeutics (R21/R33) |
93.279, 93.853 |
RFA-NS-16-013 |
| CTSA Network - Trial Innovation Centers (TICs) (U24) |
93.350, 93.866 |
RFA-TR-15-002 |
| Alzheimer's Drug-Development Program (U01) |
93.866 |
PAR-15-174 |
Search Results 6121-6160 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
